Walleye Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Walleye Capital’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-40,306	Closed	-$2.08M	–	4086
2022 Q3	$2.08M	Buy	+40,306	New	+$1.67M	0.04%	543
2022 Q2	–	Sell	-34,651	Closed	-$869K	–	2843
2022 Q1	$869K	Buy	+34,651	New	+$974K	0.02%	697
2021 Q3	–	Sell	-18,996	Closed	-$254	–	1952
2021 Q2	$254	Buy	+18,996	New	+$468K	0.01%	990

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Capital's CCXI Position: Q4 2022 in Review

Walleye Capital sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 40,306 shares — an estimated $2.08M sold.

Walleye Capital first reported a position in CCXI in Q2 2021 and held it in 3 quarters. The position peaked at $2.08M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Walleye Capital reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Walleye Capital sold 40,306 ChemoCentryx, Inc. shares in Q4 2022, an estimated $2.08M.
Walleye Capital first reported a position in ChemoCentryx, Inc. in Q2 2021 and held it in 3 quarters.
Walleye Capital's ChemoCentryx, Inc. position peaked at $2.08M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.